scholarly journals Publication speed in pharmacy practice journals: A comparative analysis

PLoS ONE ◽  
2021 ◽  
Vol 16 (6) ◽  
pp. e0253713
Author(s):  
Antonio M. Mendes ◽  
Fernanda S. Tonin ◽  
Felipe F. Mainka ◽  
Roberto Pontarolo ◽  
Fernando Fernandez-Llimos

Background Scholarly publishing system relies on external peer review. However, the duration of publication process is a major concern for authors and funding bodies. Objective To evaluate the duration of the publication process in pharmacy practice journals compared with other biomedical journals indexed in PubMed. Methods All the articles published from 2009 to 2018 by the 33 pharmacy practice journals identified in Mendes et al. study and indexed in PubMed were gathered as study group. A comparison group was created through a random selection of 3000 PubMed PMIDs for each year of study period. Articles with publication dates outside the study period were excluded. Metadata of both groups of articles were imported from PubMed. The duration of editorial process was calculated with three periods: acceptance lag (days between ‘submission date’ and ‘acceptance date’), lead lag (days between ‘acceptance date’ and ‘online publication date’), and indexing lag (days between ‘online publication date’ and ‘Entry date’). Null hypothesis significance tests and effect size measures were used to compare these periods between both groups. Results The 33 pharmacy practice journals published 26,256 articles between 2009 and 2018. Comparison group random selection process resulted in a pool of 23,803 articles published in 5,622 different journals. Acceptance lag was 105 days (IQR 57–173) for pharmacy practice journals and 97 days (IQR 56–155) for the comparison group with a null effect difference (Cohen’s d 0.081). Lead lag was 13 (IQR 6–35) and 23 days (IQR 9–45) for pharmacy practice and comparison journals, respectively, which resulted in a small effect. Indexing lag was 5 days (IQR 2–46) and 4 days (IQR 2–12) for pharmacy practice and control journals, which also resulted in a small effect. Slight positive time trend was found in pharmacy practice acceptance lag, while slight negative trends were found for lead and indexing lags for both groups. Conclusions Publication process duration of pharmacy practice journals is similar to a general random sample of articles from all disciplines.

2020 ◽  
Vol 4 (1) ◽  
Author(s):  
Christopher Uggen ◽  
Ráchael A. Powers ◽  
Heather McLaughlin ◽  
Amy Blackstone

Public attention to sexual harassment has increased sharply with the rise of the #MeToo movement, although the phenomenon has sustained strong scientific and policy interest for almost 50 years. A large and impressive interdisciplinary scholarly literature has emerged over this period, yet the criminology of sexual harassment has been slow to develop. This review considers how criminological theory and research can advance knowledge on sexual harassment—and how theory and research on sexual harassment can advance criminological knowledge. We review classic and contemporary studies and highlight points of engagement in these literatures, particularly regarding life-course research and violence against women. After outlining prospects for a criminology of sexual harassment that more squarely addresses perpetrators as well as victims, we discuss how criminological insights might contribute to policy efforts directed toward prevention and control. Expected final online publication date for the Annual Review of Criminology, Volume 4 is January 13, 2021. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.


2021 ◽  
Vol 73 (1) ◽  
Author(s):  
Catherine Jacob-Dolan ◽  
Dan H. Barouch

The worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to the unprecedented pace of development of multiple vaccines. This review evaluates how adenovirus (Ad) vector platforms have been leveraged in response to this pandemic. Ad vectors have been used in the past for vaccines against other viruses, most notably HIV and Ebola, but they never have been produced, distributed, or administered to humans at such a large scale. Several different serotypes of Ads encoding SARS-CoV-2 Spike have been tested and found to be efficacious against COVID-19. As vaccine rollouts continue and the number of people receiving these vaccines increases, we will continue to learn about this vaccine platform for COVID-19 prevention and control. Expected final online publication date for the Annual Review of Medicine, Volume 73 is January 2022. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.


Author(s):  
Andrew G. Alleyne ◽  
Christopher T. Aksland

This article outlines the importance of electrified mobility (e-mobility) in modern transport. One key goal of this review is to illustrate the role that control has played, and must continue to play, as e-mobility grows. The coordination of power in multiple modes (mechanical, electrical, and thermal) requires sophisticated controller algorithms. This review advocates for model-based approaches to control since there may not be readily available physical systems from which to gather data and do data-based control. A second goal of the article is to present methods for modeling these powertrain systems that are modular, scalable, flexible, and computationally efficient. A graph-based approach satisfies many of the desired criteria. The third goal is to review control approaches for these classes of systems and detail a hierarchical approach that makes trades across different domains of power. Optimization-based approaches are well suited to achieving the regulation and tracking goals, along with the minimization of costs and the satisfaction of constraints. Multiple examples, within this article and the references therein, support the presentation throughout. This field of e-mobility is rapidly growing, and control engineers are uniquely positioned to have an impact and lead many of the critical developments. Expected final online publication date for the Annual Review of Control, Robotics, and Autonomous Systems, Volume 5 is May 2022. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.


2005 ◽  
Vol 55 (3) ◽  
pp. 255-269 ◽  
Author(s):  
András Simonovits

According to the dominant view, the quality of individual scientific papers can be evaluated by the standard of the journal in which they are published. This paper attempts to demonstrate the limits of this view in the field of economics. According to our main findings, a publication frequently serves as a signal of high professional standards rather than as a source of information; referees and editors frequently reject good papers and accept bad ones; citation indices only partially balance the distortions deriving from the selection process; there are essential “entry costs” to the publication process. Moreover, financial interests of publishers may contradict scientific interests. As long as leading economists do not give voice to their dissatisfaction, there is no hope for any reform of the selection process.


2017 ◽  
pp. 19-24
Author(s):  
O.V. Grishchenko ◽  
◽  
V.V. Bobrytska ◽  

The objective: To evaluate the clinical efficacy and safety of Enoxaparin-Pharmex for the prevention of thrombotic complications (pulmonary embolism) in the postoperative period in patients with moderate risk of these complications. Patients and methods. The study included 50 women after a caesarean section had an average degree of risk of pulmonary embolism. Patients were divided into the main group (n=25) and control group (n=25) in accordance with the treatment: patients of the main group received postoperative Еnoxaparin- Pharmex, group comparisons enoxaparin sodium (brand foreign manufacturer’s). Patients in both groups received the drug at a dose of 20 mg for 5 days, 1 time per day subcutaneously. Results. The research data analysis showed identity results of hemostasiogram of patients in the main group and the comparison group, no side effects after treatment in both groups. Conclusion. The clinical studies suggest the drug Enoxaparin-Pharmex is effective, safe LMWH, which can be used to prevent troboembolic complications, including post-operative treatment in obstetric practice. Spectrum of Enoxaparin-Pharmex can be extended to the prevention and treatment of thromboembolic conditions of varying severity with appropriate doses of the drug. Key words: Enoxaparin-Pharmex, prevention of pulmonary embolism.


This handbook is currently in development, with individual articles publishing online in advance of print publication. At this time, we cannot add information about unpublished articles in this handbook, however the table of contents will continue to grow as additional articles pass through the review process and are added to the site. Please note that the online publication date for this handbook is the date that the first article in the title was published online. For more information, please read the site FAQs.


This handbook is currently in development, with individual articles publishing online in advance of print publication. At this time, we cannot add information about unpublished articles in this handbook, however the table of contents will continue to grow as additional articles pass through the review process and are added to the site. Please note that the online publication date for this handbook is the date that the first article in the title was published online. For more information, please read the site FAQs.


This handbook is currently in development, with individual articles publishing online in advance of print publication. At this time, we cannot add information about unpublished articles in this handbook, however the table of contents will continue to grow as additional articles pass through the review process and are added to the site. Please note that the online publication date for this handbook is the date that the first article in the title was published online. For more information, please read the site FAQs.


This handbook is currently in development, with individual articles publishing online in advance of print publication. At this time, we cannot add information about unpublished articles in this handbook, however the table of contents will continue to grow as additional articles pass through the review process and are added to the site. Please note that the online publication date for this handbook is the date that the first article in the title was published online. For more information, please read the site FAQs.


This handbook is currently in development, with individual articles publishing online in advance of print publication. At this time, we cannot add information about unpublished articles in this handbook, however the table of contents will continue to grow as additional articles pass through the review process and are added to the site. Please note that the online publication date for this handbook is the date that the first article in the title was published online. For more information, please read the site FAQs.


Sign in / Sign up

Export Citation Format

Share Document